Korean Journal of Clinical Oncology

Aims & Scope

The Korean Journal of Clinical Oncology (Korean J Clin Oncol, KJCO) is an official publication of the Korean Society of Surgical Oncology. KJCO serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. This journal aims to extend the lifespan and improve the quality of life for cancer patients through comprehensive research, not only focused on cancer treatment but also covering a broad range of cancer-related studies. Its scope includes a wide range of tumors, such as gastrointestinal, breast, head and neck cancers, soft tissue tumors, and tumors of other organs. To this end, KJCO welcomes submissions across a broad spectrum of topics within clinical oncology, including but not limited to: The journal publishes original articles, reviews, case reports, correspondences, editorials. The journal is published three times a year, in April, August, and December, and is distributed to members of the Korean Society of Surgical Oncology, medical schools, libraries, and related institutes to advance academic knowledge in clinical oncology and promote active communication between members and international societies of clinical oncology. We invite researchers and clinicians to submit their latest findings and perspectives, contributing to a vibrant, interdisciplinary dialogue that will shape the future of clinical oncology.

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

Subject Classification